The stock and fortunes of antibiotic-developer Spero Therapeutics (SPRO) looked like they were about to get flushed down the toilet … until last week. The company’s primary and only signi...
The stock and fortunes of antibiotic-developer Spero Therapeutics (SPRO) looked like they were about to get flushed down the toilet … until last week. The company’s primary and only signi...